188 related articles for article (PubMed ID: 29661717)
1. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
[TBL] [Abstract][Full Text] [Related]
2. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
[TBL] [Abstract][Full Text] [Related]
3. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
Yang WT; Xu YX; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
[TBL] [Abstract][Full Text] [Related]
6. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
8. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases.
Moran CA; Suster S
Mod Pathol; 2000 May; 13(5):489-94. PubMed ID: 10824919
[TBL] [Abstract][Full Text] [Related]
9. Loss of cell cohesion in breast cytology as a characteristic of neuroendocrine carcinoma.
Tang W; Taniguchi E; Wang X; Mori I; Kagiya T; Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Sakurai T; Kakudo K
Acta Cytol; 2002; 46(5):835-40. PubMed ID: 12365216
[TBL] [Abstract][Full Text] [Related]
10. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
Ding HY; Gao LX
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
[TBL] [Abstract][Full Text] [Related]
11. Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature.
Eichhorn JH; Lawrence WD; Young RH; Scully RE
Int J Gynecol Pathol; 1996 Oct; 15(4):303-14. PubMed ID: 8886877
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiated carcinomas of the breast: a distinct entity.
Zekioglu O; Erhan Y; Ciriş M; Bayramoglu H
Breast; 2003 Aug; 12(4):251-7. PubMed ID: 14659309
[TBL] [Abstract][Full Text] [Related]
13. A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.
Okoshi K; Saiga T; Hisamori S; Iwaisako K; Kobayashi H; Ogawa H
Breast Cancer; 2012 Oct; 19(4):360-4. PubMed ID: 19669861
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance.
Kawasaki T; Mochizuki K; Yamauchi H; Inoue S; Kondo T; Oishi N; Nakazawa T; Yamane T; Koshimizu Y; Tsunoda H; Yagata H; Inoue M; Inoue A; Maruyama T; Fujii H; Katoh R
J Clin Pathol; 2012 Aug; 65(8):699-703. PubMed ID: 22554967
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration cytology of ductal breast carcinoma with neuroendocrine differentiation. Review of eight cases with histologic correlation.
Ng WK; Poon CS; Kong JH
Acta Cytol; 2002; 46(2):325-31. PubMed ID: 11917580
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
17. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the parotid gland: report of three cases with contemporary review of salivary neuroendocrine carcinomas.
Said-Al-Naief N; Sciandra K; Gnepp DR
Head Neck Pathol; 2013 Sep; 7(3):295-303. PubMed ID: 23456649
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature.
Kadir AA; Iyengar KR; Peh SC; Yip CH
Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413
[TBL] [Abstract][Full Text] [Related]
19. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of solid papillary carcinoma of breast].
Wei B; Bu H; Chen HJ; Zhang HY; Li XJ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):589-93. PubMed ID: 17134565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
